You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 117 No. 1, January 1991 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Drug Response of Head and Neck Tumors in Native-State Histoculture

K. T. Robbins, MD; N. M. Varki, MD; A. M. Storniolo, MD; H. Hoffman, MD; R. M. Hoffman, PhD

Arch Otolaryngol Head Neck Surg. 1991;117(1):83-86.


Abstract

• We describe a chemosensitivity testing of head and neck tumors, in which a native-state histoculture, ie, a three-dimensional culture system that maintains important in vivo properties, including tissue architecture, was used. Fifteen specimens of head and neck tumors were evaluated for sensitivity to the following drugs: cisplatin (DDP) at concentrations of 1.5, 15, and 37.5 µg/mL; fluorouracil at concentrations of 4.0, 40, and 100µg/mL; and combinations of cisplatin and fluorouracil in corresponding doses. Growth and measurement of drug responses were successfully completed in 10 specimens (five others were contaminated, four of them prior to instituting rigorous antibiotic washes). The results indicated cisplatin sensitivity in five of 10 patients; fluorouracil sensitivity in four of 10 patients; and fluorouracil-cisplatin sensitivity in seven of eight patients. Our preliminary results indicate that the native-state histoculture technique is feasible to test chemosensitivity of head and neck tumors.

(Arch Otolaryngol Head Neck Surg. 1991;117:83-86)



Author Affiliations

From the Division of Otolaryngology—Head and Neck Surgery (Drs Robbins and H. Hoffman), Laboratory of Cancer Biology, Department of Pediatrics (Dr R. M. Hoffman), and Division of Hematology and Oncology (Drs Storniolo and Varki), University of California School of Medicine, La Jolla; and the AntiCancer Inc, San Diego, Calif (Dr R. M. Hoffman).


Footnotes

Accepted for publication September 4, 1990.

Reprint requests to Head and Neck Oncology, University of California San Diego Cancer Center, 225 Dickinson St, H891B, San Diego, CA 92103 (Dr Robbins).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Polymer Delivery of Chemotherapy for Squamous Cell Carcinoma of the Head and Neck
Shikani et al.
Arch Otolaryngol Head Neck Surg 1994;120:1242-1247.
ABSTRACT  

Sponge-Gel-Supported Histoculture Drug-Response Assay for Head and Neck Cancer: Correlations With Clinical Response to Cisplatin
Robbins et al.
Arch Otolaryngol Head Neck Surg 1994;120:288-292.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1991 American Medical Association. All Rights Reserved.